Scilex Holding Co

Scilex Holding Company (Nasdaq: SCLX) is a specialty pharmaceutical company focused on non-opioid pain management that completed its business combination with Vickers Vantage Corp. I, a blank-check company sponsored by Vickers Vantage Sponsor One LLC following its 2021 IPO. The company filed an 8-K with the SEC on March 21, 2022, in connection with its de-SPAC transaction process. Scilex's commercial portfolio centers on FDA-approved topical pain therapies, positioning the combined entity within the specialty pharmaceuticals sector. The transaction closed and the combined company now trades on Nasdaq under the ticker SCLX. For full filing history, deal timelines, and SPAC analytics on SCLX and hundreds of other transactions, sign up for SpacDesk at spacdesk.com.